Development of a rift valley fever virus viremia challenge model in sheep and goats

Vaccine

Volumn 32, Issue 20, 2014, Pages 2337-2344

  Weingartl, Hana M ^a,b   Miller, Myrna ^c   Nfon, Charles ^a   Wilson, William C ^d  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF WYOMING   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Real time RT PCR; Rift Valley fever; Viremia; Virus isolation

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EXPERIMENTAL GOAT; EXPERIMENTAL INFECTION; EXPERIMENTAL SHEEP; INOCULATION; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REAL TIME POLYMERASE CHAIN REACTION; RECTUM TEMPERATURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; VERO CELL; VIREMIA; VIRUS DETECTION; VIRUS ISOLATION; VIRUS PLAQUE;

REAL-TIME RT-PCR; RIFT VALLEY FEVER; VIREMIA; VIRUS ISOLATION;

AEDES; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; GOAT DISEASES; GOATS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RNA, VIRAL; SHEEP; SHEEP DISEASES; VERO CELLS; VIREMIA; VIRUS CULTIVATION;

EID: 84897568000     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.066     Document Type: Article

References (30)

1. Pepin M., Bouloy M., Bird B.H., Kemp A., Paweska J. Rift Valley fever virus (Bunayviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 2010, 41:61. 10.1051/vetres/2010033.
2. Flick R., Bouloy M. Rift Valley fever virus. Curr Mol Med 2005, 5:827-834.
3. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting. Bull World Health Organ 1983, 61:261-268.
4. Boshra H., Lorenzo G., Busquets N., Brun A. Rift Valley fever: recent insights into pathogenesis and prevention. J Virol 2011, 85:6098-6105.
5. Kortekaas J., Antonis A.F.G., Kant J., Vloet R.P.M., Vogel A., Oreshkova N., et al. Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine 2012, 30:3423-3429.
6. Bird B.H., Maartens L.H., Campbell S., Erasmus B.J., Erickson B.R., Dodd K.A., et al. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J Virol 2011, 85:12901-12909.
7. Dungu B., Louw I., Lubisi A., Hunter P., von Teichman B.F., Bouloy M. Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep. Vaccine 2010, 28:4581-4587.
8. Morill J.C., Mebus C.A., Peters C.J. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. AJVR 1997, 58:1104-1109.
9. Drolet B.S., Weingartl H.M., Jiang J., Neufeld J., Marszal P., Lindsay R., et al. Development and evaluation of one-step rRT-PCR and immunohisto-chemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories. J Virol Methods 2012 Feb, 179(2):373-382. 2012.
10. Busquets N., Xavier F., Martín-Folgar R., Lorenzo G., Galindo-Cardiel I., del Val B.P., et al. Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates. Vector Borne Zoonotic Dis 2010, 10(October (7)):689-696. 10.1089/vbz.2009.0205.
11. Tomori O. Clinical, virological and serological response of the West African dwarf sheep to experimental infection with different strains of Rift Valley fever virus. Res Vet Sci 1979, 26:152-159.
12. Yedloutschnig R.J., Dardiri A.H., Mebus C.A., Walker J.S. Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus. Vet Rec 1981, 109:383-384.
13. Yedloutschnig R.J., Dardiri A.H., Walker J.S. Rift Valley fever infection in sheep by contact exposure. Contrib Epidemiol Biostat 1981, 3:53-59.
14. Olaleye O.D., Tomori O., Fajimi J.L., Schmitz H. Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley fever virus. Rev Elev Med Vet Pays Trop 1996, 49:6-16.
15. Easterday B.C., Murphy L.C., Bennet D.G. Experimental Rift Valley fever in lambs and sheep. Am J Vet Res 1962, 23:1231-1240.
16. Easterday B.C., Murphy L.C., Bennet D.G. Experimental Rift Valley fever in calves, goats, and pigs. Am J Vet Res 1962, 23:1224-1230.
17. Iman Z.E.I., El-Karamany R., Kasem S. Studies on goats experimentally infected with R.V.F. virus. J Egypt Public Health Assoc 1978, LIII:273-280.
18. Fagbami A.H., Tomori O., Fabiyi A., Isoun T.T. Experimental Rift Valley fever in West African Dwarf sheep. Res Vet Sci 1975, 18:334-335.
19. Ross T.M., Bhardwaj N., Bissel S.J., Hartman A.L., Smith D.R. Animal models of Rift Valley fever virus infection. Virus Res 2012, 163:417-423.
20. Kamal S.A. Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol J 2009, 6:94. 10.1186/1743-422X-6-94.
21. Nfon C.K., Marszal P., Zhang S., Weingartl H.M. Innate immune response to Rift Valley fever virus in goats. PLoS Negl Trop Dis 2012, 6:e1623. 10.1371/journal.pntd.0001623.
22. Rossi C.A., Turell M.J. Characterization of attenuated strains of Rift Valley fever virus. J Gen Virol 1988, 69:817-823.
23. Weingartl H.M., Zhang S., Marszal P., McGreevy A., Burton L., Wilson W.C. Rift Valley fever virus incorporates the 78kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS ONE 2014, 9:e87385. eCollection 2014. 10.1371/journal.pone.0087385.
24. Weingartl H.M., Nfon C.K., Zhang S., Marszal P., Wilson W.C., Morill J.C., Bettinger G.E., Peters C.J. Efficacy of recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep. Vaccine 2014, [epub ahead of print]. 10.1016/j.vaccine. 2013.12.064.
25. Moutailler S., Roche B., Thiberge J.M., Caro V., Rougeon F., Failloux A.B. Host alternation is necessary to maintain the genome stability of Rift Valley fever virus. PLoS Negl Trop Dis 2011, 5:e1156. 10.1371/journal.pntd.0001156.
26. Lozach P.Y., Kuhbacher A., Meier R., Mancini R., Bitto D., Bouloy M. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011, 10:75-88.
27. Klimstra W.B., Nangle E.M., Smith M.S., Yurochko A.D., Ryman K.D. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 2003, 77:12022-12032.
28. Shabman R.S., Morrison T.E., Moore C., White L., Suthar M.S., Hueston L. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol 2007, 81:237-247.
29. Silva M.C., Guerrero-Plata A., Gilfoy F.D., Garofalo R.P., Mason P.W. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol 2007, 81:13640-13648.
30. Smith D.R., Bird B.H., Lewis B., Johnston S.C., McCarthy S., Keeney A., et al. Development of a novel nonhuman primate model for Rift Valley fever. J Virol 2012, 86:2109-2120.